Drusen-associated degeneration in the retina

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 10, 2003, Pages 4481-4488

  Johnson, Patrick T ^a   Lewis, Geoffrey P ^a   Talaga, Kevin C ^a   Brown, Meghan N ^a   Kappel, Peter J ^a   Fisher, Steven K ^a   Anderson, Don H ^a   Johnson, Lincoln V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; GLIAL FIBRILLARY ACIDIC PROTEIN; OPSIN; VIMENTIN;

ANTIBODY LABELING; ARTICLE; BRUCH MEMBRANE; CHOROID; CONFOCAL MICROSCOPY; DRUSEN; HUMAN; HUMAN TISSUE; MUELLER CELL; NERVE ENDING; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA AMACRINE CELL; RETINA BIPOLAR GANGLION CELL; RETINA CONE; RETINA DEGENERATION; RETINA HORIZONTAL NERVE CELL; RETINA MACULA AGE RELATED DEGENERATION; RETINA ROD;

AGED; AGED, 80 AND OVER; AXONS; CHOROID; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MIDDLE AGED; NEUROGLIA; OPSIN; PHOTORECEPTORS, VERTEBRATE; PIGMENT EPITHELIUM OF EYE; RETINA; RETINAL DRUSEN; VIMENTIN;

EID: 0141430046     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0436     Document Type: Article

References (45)

1. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res. 2001;20:227-253.
2. Green RW. Histopathology of age-related macular degeneration. Molec Vis. 1999;5:27-36.
3. Curcio CA, Medeiros NE, Millican CL. The Alabama Age-Related Macular Degeneration Grading System for donor eyes. Invest Ophthalmol Vis Sci. 1998;39:1085-1096.
4. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411-431.
5. Curcio CA, Medeiros NE, Millican CL. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1236-1249.
6. Hageman GS, Luthert PJ, Victor-Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705-732.
7. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Ret Eye Res. 2001;385-414.
8. Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in drusen formation and Age-related Macular Degeneration. Exp Eye Res. 2001;73:887-896.
9. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol. 1999;83:358-368.
10. Sarks SH. Drusen patterns predisposing to geographic atrophy of the retinal pigment epithelium. Aust J Ophthalmol. 1982;10:91-97.
11. Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina. 1994;14:130-142.
12. Madigan MC, Penfold PL, Provis JM, Balind TK, Billson FA. Intermediate filament expression in human retinal macroglia. Histopathologic changes associated with age-related macular degeneration. Retina. 1994;14:65-74.
13. Guidry C, Medeiros NE, Curcio CA. Phenotypic variation of retinal pigment epithelium in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2002;43:267-273.
14. Dunaief JL, Dentchev T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 2002;120:1435-1442.
15. Ramirez JM, Ramirez AI, Salazar JJ, de Hoz R, Trivino A. Changes of astrocytes in retinal ageing and age-related macular degeneration. Exp Eye Res. 2001;73:601-615.
16. Medeiros NE, Curcio CA. Preservation of ganglion cell layer neurons in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2001;42:795-803.
17. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367-374.
18. Anderson DH, Ozaki S, Nealon, M, et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol. 2001;131:767-781.
19. Coblentz FE, Radeke MJ, Lewis GP, Fisher SK. Evidence that ganglion cells react to retinal detachment. Exp Eye Res. 2003;76:333-342.
20. Pauleikhoff D, Barondes M, Minassian D, Chisolm I, Bird AC. Drusen as risk factors in age-related macular disease. Am J Ophthalmol. 1990;109:38-43.
21. Bressler SB, MacGuire G, Bressler NM, Fine S. Relationship of drusen and abnormalities of the retinal pigmented epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol. 1990;108:1442-1447.
22. Fisher SK, Anderson DH. Cellular effects of detachment on the neural retina and the retinal pigment epithelium. In: Wilkinson CP, ed. Retina. 3rd ed., Vol. 3. St. Louis: Mosby; 2001:1961-1986.
23. Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001;108:1196-1202.
24. Kim SY, Sadda S, Pearlman J, et al. Morphometric analysis of the macula in eyes with disciform age-related macular degeneration. Retina. 2002;22:471-477.
25. Smith VC, Pokorny J, Diddie KR. Color matching and the Stiles-Crawford effect in observers with early age-related macular changes. J Opt Soc Am A. 1988;5:2113-2121.
26. Midena E, Segato T, Blarzino M, Angeli C. Macular drusen and the sensitivity of the central visual field. -Documenta Ophthalmol. 1994;88:179-185.
27. Sunness JS, Johnson MA, Massof RW, Marcus S. Retinal sensitivity over drusen and nondrusen areas. Arch Ophthalmol. 1988;106:1081-1084.
28. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci. 1994;91:974-978.
29. Linsenmeier RA, Padnick-Silver L. Metabolic dependence of photoreceptors on the choroid in the normal and detached retina. Invest Ophthalmol Vis Sci. 2000;41:3117-3123.
30. Mervin K, Valter K, Maslim J, Lewis G, Fisher S, Stone J. Limiting photoreceptor death and deconstruction during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol. 1999;128:155-164.
31. Sakai T, Lewis GP, Linberg KA, Fisher SK. The ability of hyperoxia to limit the effects of experimental detachment in cone dominated retina. Invest Ophthalmol Vis Sci. 2001;42:3264-3273.
32. Mervin K, Stone J. (a) Regulation by oxygen of photoreceptor death in the developing and adult C57BL/6J mouse. Exp Eye Res. 2002;75:715-722.
33. Mervin K, Stone J. (b) Developmental death of photoreceptors in the C57BL/6J mouse: association with retinal function and self-protection. Exp Eye Res. 2002;75:703-713.
34. Farkas TG, Sylvester V, Archer D. The ultrastructure of drusen. Am J Ophthalm. 1971;71:1196-1205.
35. Hogan MJ. Role of the retinal pigment epithelium in macular disease. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:64-80.
36. Burns RP, Feeney-Burns L. Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalm Soc. 1980;78:206-225.
37. Ishibashi T, Patterson R, Ohnishi Y, Inomata H, Ryan SJ. Formation of drusen in the human eye. Am J Ophthalmol. 1986;101:342-353.
38. Graymore CN. General aspects of the metabolism of the retina. In: The Eye. 2nd ed. New York: Academic Press. 1969;1:601-645.
39. Boulton M, Dayhaw-Barker P. The role of the retinal pigment epithelium: topographical variation and ageing changes. Eye. 2001;15:384-389.
40. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson, DH. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res. 2000;70:441-449.
41. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:14682-14687.
42. Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42:265-274.
43. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:11830-11835.
44. Jen LS, Hart AJ, Jen A, et al. Alzheimer's peptide kills cells of retina in vivo. Nature. 1998;392:140-141.
45. Walsh DT, Montero RM, Bresciani LG, et al. Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol Dis. 2002;10:20-27.